Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Diabetes After Gastric Bypass With Sitagliptin (LAF33)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Columbia University
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Blandine Laferrere, Columbia University
ClinicalTrials.gov Identifier:
NCT01512797
First received: January 13, 2012
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)